Novo Nordisk® Ozempic® Direct Mail

Managing type 2 diabetes is hard work and Novo Nordisk gets it. That’s why they send patients this high impact direct mail piece that literally demonstrates the company’s commitment to providing support for patients—and even their injection pens. The goal is for patients to understand that treatment is achievable, that they are far from alone as they work towards their diabetes management goals, and that they have the power within themselves to keep up the momentum on their own in the years ahead. All of which should lead to greater adherence and better outcomes.


Ozempic_Retention_Direct_Mail.jpg